Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Marshall syndrome is a malformation syndrome that is characterized by facial dysmorphism, severe hypoplasia of the nasal bones and frontal sinuses, ocular involvement, early-onset hearing loss, skeletal and anhidrotic ectodermal anomalies and short stature with spondyloepiphyseal dysplasia and early-onset osteoarthritis.
Features include always present findings: Short nose, Cataract, Midface retrusion, and Depressed nasal bridge and others; and common findings: Cleft palate, Bifid uvula, Recurrent otitis media, and Pierre-Robin sequence. 45 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 5 | Irregular distal femoral epiphysis, Knee osteoarthritis, Hypoplastic fetal nasal bone |
COL11A1 function has not been fully characterized.
Marshall syndrome is associated with mutations in the COL11A1 gene on chromosome 1.
Genetic testing for COL11A1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Marshall syndrome has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Marshall syndrome.
5 publications have been identified in PubMed for Marshall syndrome. Research spans Case Report / Case Series (40%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).
Banh Chong T (2025). [PMID: 39322492](https://pubmed.ncbi.nlm.nih.gov/39322492/). *European annals of otorhinolaryngology, head and neck diseases*. [Epidemiology / Natural History]
Nair P (2025). [PMID: 40771183](https://pubmed.ncbi.nlm.nih.gov/40771183/). *Mol Syndromol*. [Diagnostic / Biomarker]
Peschaut T (2025). [PMID: 39981533](https://pubmed.ncbi.nlm.nih.gov/39981533/). *Case Rep Ophthalmol*. [Case Report / Case Series]
Khodeir J (2024). [PMID: 38924070](https://pubmed.ncbi.nlm.nih.gov/38924070/). *International journal of dermatology*. [Review / Meta-Analysis]
Harris SR (2024). [PMID: 38062645](https://pubmed.ncbi.nlm.nih.gov/38062645/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 17, 2026, 11:16 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Marshall syndrome
Eyes |
4 |
Retinal detachment, Cataract, Lens luxation |
Head and neck | 4 | Macrodontia of permanent maxillary central incisor, Thick lower lip vermilion, Thick upper lip vermilion |
Brain and nerves | 2 | Calcification of falx cerebri, Depressed nasal bridge |
Arms and legs | 2 | Clinodactyly of the 4th finger, Clinodactyly of the 5th finger |
Ears | 2 | Inner ear hearing loss (sensorineural hearing impairment), Recurrent otitis media |
Growth and development | 1 | Short stature |
Pregnancy and birth | 1 | Hypoplastic fetal nasal bone |
Age of onset: middle age, childhood.